Development of a Novel, Integrative Bioinformatics Approach for Bispecific Target Selection & Validation
Time: 2:30 pm
day: Conference Day Two
Details:
- Integrating expression profiles with antigen biology for improved target selection
- Exploring preclinical efficacy data with novel bispecific agents with implications for disease positioning
- Discussing the importance of bispecific selectivity for improved therapeutic index and addressing the challenges of demonstrating this in preclinical models